The Errand That Rode in the Passenger Seat

The parcel made it into the car. For a moment, that felt like the difficult part was over.

Then it went to work. It went to the supermarket. It went through a car wash.

By the end of the week, it has acquired a history. You have to find the return email again. You have to check the deadline. When a friend needs the passenger seat, you put the box in the back.

Someone could tell you that the errand takes five minutes. You know. You have spent far more than five minutes thinking about those five minutes.

The part other people don't see

One public writer describes attention difficulties that followed them through years of study and into work.[2] Another describes a continuing problem getting started on tasks and asks other people what has helped.[3]

The bigger picture looks less like a shortage of ambition than a problem with the ordinary mechanics of a day: getting organized, remembering what needs doing, following through. An estimated 15.5 million U.S. adults reported a current ADHD diagnosis in 2023.[5]

A 2025 study of 2,257 adults diagnosed with ADHD at Dutch mental health clinics puts numbers to those difficulties. Across the men and women in the study, 85–90% had difficulty organizing tasks and activities, and 77–81% were forgetful in daily activities.[6] These are figures from a clinical sample, not percentages of all adults.

Behind those numbers are unfinished tasks, misplaced items and obligations that slip away. The wider challenge is making daily life work, not simply telling people to try harder.

Executive dysfunction is here to stay.

What people went looking for

The first writer later described trying Semax. Their account was modest: an afternoon that felt a little steadier, uncertainty about placebo, and a price they did not want to pay again.[2] A different writer, describing their ADHD as self-diagnosed, reported a much more dramatic experience with Semax and Selank, including household and repair tasks they said they finished.[4]

The disagreement is part of the story. People can recognize the same frustration, search in a similar direction and come back with very different accounts. The search is shared; the endings are not.

Under both accounts is a stubbornly ordinary wish: for an action to stop demanding so much of the day before it is even done.

Suppose the parcel finally reaches the counter. The label is scanned. No one asks why it took a week. A receipt prints, and the box ceases to be your passenger.

You do not need to turn that receipt into a promise about every future Tuesday. You can just leave the shop without carrying the box.

For laboratory researchers following the Semax and Selank discussion: Olympus Peptide Labs lists research materials and available product documentation to inspect before a laboratory purchase. The writers above did not identify Olympus as their source, and their accounts do not establish effects for its products.

Examine the Olympus research catalogue

Source note

The parcel is an invented illustration, not testimony or a diagnostic test. [1] NIMH on adult ADHD describes persistent difficulties with organization, planning and daily tasks; one delayed errand is not a diagnosis. [2] Public Semax account. [3] Public account seeking advice. [4] Public Semax and Selank account. These are unverified self-reports. Olympus materials are marketed for in-vitro laboratory research, not personal treatment.

[5] Staley BS, Robinson LR, Claussen AH, et al. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults—United States, October–November 2023. MMWR. 2024;73:890–895. National adult survey; current diagnosis based on self-report. Accessed November 2, 2026.

[6] Platania NM, Starreveld DEJ, Wynchank D, Beekman ATF, Kooij S. Bias by gender: exploring gender-based differences in the endorsement of ADHD symptoms and impairment among adult patients. Frontiers in Global Women’s Health. 2025;6:1549028. Published March 20, 2025. doi:10.3389/fgwh.2025.1549028. Clinical sample of 2,257 adults diagnosed with ADHD in the Netherlands; percentages describe the male and female groups, rounded to whole numbers. Accessed November 2, 2026.

Related reading: Why the Peptide Story Is So Persuasive.